USPTO trademark

ACTLONCI

Under examinationUSPTOWord markClass 5

"ACTLONCI" is a word mark owned by Merck Sharp & Dohme B.V., filed at the USPTO on March 6, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Merck Sharp & Dohme B.V. portfolioGet this data via the API
Official USPTO record
ACTLONCI trademark as filed
As filed with the USPTO
Status
Under examination
Since August 7, 2026
Filed
March 6, 2026
Registered
Not yet
Priority date
March 4, 2026
Application no.
99687843
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ACTLONCI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Merck Sharp & Dohme B.V.

Haarlem, Netherlands

1,694 trademarks in the portfolioView company

Representative

Palak Mayani

Merck & Co., Inc.

Goods and services

What the mark covers

The products and services ACTLONCI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. On hold - electronic record review required
  2. Approved for pub - principal register
  3. Teas/email correspondence entered
  4. Correspondence received in law office
  5. Teas response to suspension inquiry received
  6. Notification of letter of suspension e-mailed
  7. Letter of suspension e-mailed
  8. Suspension letter written
  9. Assigned to examiner
  10. Application filing receipt mailed

2 earlier steps on the official record.

FAQ

About ACTLONCI

Who owns the trademark "ACTLONCI"?

The USPTO trademark "ACTLONCI" (application 99687843) is owned by Merck Sharp & Dohme B.V.

What is the status of "ACTLONCI"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ACTLONCI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d3ecb-087f-7499-851f-71ed0a0a475c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d3ecb-087f-7499-851f-71ed0a0a475c",
  "object": "trademark",
  "mark_text": "ACTLONCI",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99687843",
  "filing_date": "2026-03-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Merck Sharp & Dohme B.V.",
      "entity_id": "ent_019f1c88-62cf-7129-9cd2-817c70bcb6bc"
    }
  ]
}